March 4, 2026

Droplet improves genomic analysis speed using NVIDIA Parabricks software

​Droplet Biosciences has reported a reduction in genomic analysis turnaround time for residual cancer detection by adopting GPU-accelerated workflows using...

March 4, 2026

Kyowa Kirin discontinues ongoing trials of rocatinlimab

​Kyowa Kirin has announced the global discontinuation of all ongoing clinical trials for rocatinlimab, an anti-OX40 monoclonal antibody under investigation...

March 4, 2026

Esperion to acquire Corstasis for cardiovascular franchise expansion

​Esperion is to acquire Corstasis Therapeutics to expand its cardiovascular franchise with the addition of Enbumyst, a bumetanide nasal spray.The...

March 3, 2026

Roche’s Phase III trial of fenebrutinib in RMS meets primary endpoint

​Roche has reported that the pivotal Phase III FENhance 1 trial of its investigational BTK inhibitor, fenebrutinib, in RMS, achieved...

March 3, 2026

PHCbi unveils cell expansion system for research use 

​PHCbi has introduced the cell expansion system, LiCellGrow, designed for research purposes in Japan and certain other countries globally.The post...

March 3, 2026

Kairos Pharma signs deal for Celyn Therapeutics’ CL-273

​Kairos Pharma has signed a binding agreement to acquire exclusive worldwide rights to CL-273 from Celyn Therapeutics.The post Kairos Pharma...

March 2, 2026

FDA grants PMA to Synergy’s cervical disc

​Synergy Spine Solutions has received PMA from the FDA for the Synergy Disc, expanding cervical disc replacement options for US...

March 2, 2026

Opus Genetics reports Phase I/II trial results of OPGx-BEST1 gene therapy

​Opus Genetics has reported early findings from its ongoing Phase I/II clinical trial of the OPGx-BEST1 gene therapy to treat...

March 2, 2026

BioMarin receives FDA approval for Palynziq use in adolescents

​BioMarin Pharmaceutical has received FDA approval for its sBLA for Palynziq’s use in adolescents aged 12 years and above with...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.